1. MARKETS
  2. SECTOR : CHEMICALS & PETROCHEMICALS
  3. INDUSTRY : SPECIALTY CHEMICALS
  4. CAMLIN FINE SCIENCES LTD.
Camlin Fine Sciences Ltd.
NSE: CAMLINFINE | BSE: 532834
Export DemandEBITDA per Kg
Ask AI about Camlin Fine Sciences
90.18-0.60(-0.66%)
460.4K
NSE+BSE Volume

NSE 14 Oct, 2026 2:37 PM (IST)

Portfolio

Alert

My Notes

Camlin Fine Sciences quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Camlin Fine Sciences share price target, revenues, EPS, net income and more

Camlin Fine Sciences quarterly results: revenue, profit, and P&L – 13 quarter history

  • POSITIVE

    Quarterly Revenue Camlin Fine Sciences Jun-2026 Quarterly Revenue is Rs 224 Cr which is growth of 14.7% YoY.

  • NEGATIVE

    Quarterly Net Profit Camlin Fine Sciences Jun-2026 Quarterly Net Profit is Rs -12 Cr which is growth of -15.3% YoY.

Camlin Fine Sciences Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
⌄
223.9198.8224.7254.2195.1281.5211.9230183.7225.9187.7211.9167.1
Operating Exp.
215.7177.5199.9225.8186.8239.3188.7212.9175246179.7184.9136
Operating Profit
6.861918.24.733.316.4146.9-25.75.921.425.1
Operating Profit Margin %
3.07%3.27%8.68%7.46%2.45%12.20%7.99%6.17%3.81%-11.64%3.17%10.36%15.58%
Depr.
13.513.313.513.513.413.113.313.412.712.812.412.411.8
Interest
13.422.114.918.711.317.417.217.913.613.913.315.112.1
Profit Before Tax
-18.7-16.6-17.3-3.8-16.411.9-7.2-110.5-17.6-48.7-17.7-0.57.3
Tax
-6.4-11-4.3-0.2-5.7-3.7-1.6-37.9-3.9-4.6-6.10.91.5
Net Profit
-12.3-5.7-13-3.6-10.715.6-5.6-72.6-13.7-44.1-11.6-1.55.8
EPS Adj. latest
-0.6-0.3-0.7-0.2-0.60.8-0.3-3.8-0.7-2.3-0.6-0.10.3
Net profit TTM
-34.6-33-11.7-4.3-73.3-76.3-136-142-70.9-51.40.527.948.1
Basic EPS TTM
-1.8-1.7-0.6-0.2-3.9-4.1-8.1-8.5-4.2-3.101.72.9
Earnings Transcripts
AI Summary
    
  
Results PDF
Result Notes
 
*All financials are in INR Cr and price data in INR

Camlin Fine Sciences competitor comparison and performance snapshot within industry

Camlin Fine Sciences revenue mix: sales, profit, and capital employed breakups by segment

Camlin Fine Sciences annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

  • NEGATIVE

    Annual Revenue Camlin Fine Sciences Mar-2026 Annual Revenue is Rs 873 Cr which is growth of -3.8% YoY.

  • POSITIVE

    Annual Net Profit Camlin Fine Sciences Mar-2026 Annual Net Profit is Rs -33 Cr which is growth of 56.8% YoY.

Camlin Fine Sciences Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
2.2%
7.6%
901.6872.9907.1792.1818.3704.2605.5603.8561.8412.1337.5415.9
Operating Exp. Ann.
6.1%
8%
818.9790815.9746.1661.9608538.2520.1518.2397.1302.6344.7
Operating Profit Ann.
-27.9%
-5%
5047.970.627.1127.677.561.959.7305.822.167.5
OPM Ann. %
-29.4%
-11.7%
 5.49%7.78%3.42%15.59%11.00%10.22%9.89%5.33%1.40%6.54%16.24%
⌄
6.6%
9.1%
 910.7934.5849.9751.6668.1590559.4547.6430.2337.4376.6
EBITDA Ann.
-19.1%
4.2%
 82.891.246156.496.267.383.843.61534.971.2
EBITDA Ann. margin %
-20.8%
-3.1%
 9.49%10.06%5.81%19.11%13.66%11.12%13.87%7.76%3.64%10.35%17.13%
Interest Ann.
5.6%
15.6%
696766.154.356.933.432.528.120.32423.221.8
Depr.
17.9%
22.7%
53.853.752.549.432.826.719.311.39.19.111.610.2
PBT Ann.
-
-
-56.4-54.1-123.4-59.666.636.11541.314.2-18.10.134.7
Tax Ann.
-
-
-21.8-21.1-47.1-8.219.110.26.710.63.5-3.90.99
-
-
 -33-76.3-51.447.625.98.330.710.7-14.2-0.825.8
Net Profit Ann.
-
-
-34.6-33-76.3-51.447.625.98.330.710.7-14.2-0.825.8
NPM Ann. %
-
-
 -3.93%-8.60%-6.64%6.02%3.77%1.38%5.29%1.95%-3.51%-0.24%6.24%
EPS Adj. latest Ann.
-
-
 -1.7-4-2.72.51.40.41.60.6-0.7-01.3
Result Notes
   
Annual Reports
 
*All financials are in INR Cr and price data in INR
Total Rev. Ann.
1Y CHG
-3.8%
2Y CAGR
5%
3Y CAGR
2.2%
5Y CAGR
7.6%
7Y CAGR
6.5%
10Y CAGR
7.7%
Total Revenue Annual is falling faster than historical averages.
Operating Exp. Ann.
1Y CHG
-3.2%
2Y CAGR
2.9%
3Y CAGR
6.1%
5Y CAGR
8%
7Y CAGR
6.2%
10Y CAGR
8.6%
Operating Expenses Annual Cr is falling faster than historical averages.

Camlin Fine Sciences balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

  • POSITIVE

    Total Shareholders Fund Camlin Fine Sciences Mar-2026 Total Shareholders Fund is Rs 925 Cr which is growth of 7.7% YoY.

  • POSITIVE

    Total Assets Camlin Fine Sciences Mar-2026 Total Assets is Rs 1,772 Cr which is growth of 8.8% YoY.

Camlin Fine Sciences Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
⌄
13.2%
14.9%
925.5859712.4638.8589461.3373.5344.1331.5175.7121
Minority Interest Liability Ann.
-
-
-----------
⌄
-11.7%
4.7%
221.7186.9248.8322.1283.4176.3124114.918.217.125.1
-0.4%
7.9%
621.4579.5607.5629.6470.2425.7390.6318.5328.2280.9236.4
Total Capital Plus Liabilities Ann.
3.6%
10.7%
1,771.91,628.71,5721,593.81,345.91,066.7891.4780.8677.8473.7382.4
⌄
-3.6%
11.9%
548.3578608611.4511.1312.2293.8150.291.492.790.4
⌄
5.8%
15.8%
850.5699.3711.5718.1625.4408.7380.2273.2159.6159.2108.9
1.7%
7%
921.4929.4860.5875.7720.6658511.2507.5518.1314.5273.5
Total Assets Ann.
3.6%
10.7%
1,771.91,628.71,5721,593.81,345.91,066.7891.4780.8677.8473.7382.4
Contingent Liabilities plus Commitments Ann.
12.1%
8.7%
190.4152.9144.8135.1139125.6257.7287.9242.8104.4144.6
Bonus Equity Share Capital Ann.
-
-
Non Current Investments Unquoted Book Value Ann.
2.6%
3.7%
88.463.579.981.881.873.67465.74032.36.7
Current Investments Unquoted Book Value Ann.
-
-
3.3
*All financials are in INR Cr and price data in INR
Total Assets Ann.
1Y CHG
8.8%
2Y CAGR
6.2%
3Y CAGR
3.6%
5Y CAGR
10.7%
7Y CAGR
12.4%
10Y CAGR
16.6%
Total Assets Annual growth is stable compared to historical averages.
Total Current Liabilities Ann.
1Y CHG
7.2%
2Y CAGR
1.1%
3Y CAGR
-0.4%
5Y CAGR
7.9%
7Y CAGR
10%
10Y CAGR
10.1%
Total Current Liabilities Annual Cr growth is stable compared to historical averages.
Total ShareHolders Funds Ann.
1Y CHG
7.7%
2Y CAGR
14%
3Y CAGR
13.2%
5Y CAGR
14.9%
7Y CAGR
15.2%
10Y CAGR
22.6%
Total ShareHolders Funds Annual growth is lower than historical averages.

Camlin Fine Sciences ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

  • POSITIVE

    Book Value Per Share Camlin Fine Sciences Mar-2026 Book Value Per Share is 48 Rs which is growth of 5.4% YoY.

  • POSITIVE

    ROE Camlin Fine Sciences Mar-2026 ROE is -4% which is growth of 5.3% YoY.

Camlin Fine Sciences Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
BVSH Ann.
5.8%
5.9%
48.245.742.540.737.536.230.828.427.316.912.5
RoA Ann. %
-
-
-1.86%-4.68%-3.26%2.98%1.92%0.77%3.44%1.37%-2.09%-0.16%6.73%
ROE Ann. %
-
-
-3.56%-8.88%-7.21%7.44%4.39%1.79%8.22%3.11%-4.27%-0.45%21.29%
ROCE Ann. %
-41.8%
-19.5%
2.53%3.68%-0.35%12.81%7.93%7.49%14.47%7.46%1.69%12.11%41.82%
⌄
           
⌄
           
⌄
           
Total Debt to Total Equity Ann.
-20.6%
-9%
0.50.50.710.80.80.90.90.71.31.2
*All financials are in INR Cr and price data in INR
Current Ratio Ann.
1Y CHG
-6.2%
2Y CAGR
3.5%
3Y CAGR
2.3%
5Y CAGR
-1.3%
7Y CAGR
-0.9%
10Y CAGR
2.3%
Current Ratio Annual is falling faster than historical averages.

Camlin Fine Sciences cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

  • POSITIVE

    Cash From Operating Activity Camlin Fine Sciences Mar-2026 Cash From Operating Activity is Rs 44 Cr which is growth of 101.1% YoY.

  • NEGATIVE

    Net Cash Flow Camlin Fine Sciences Mar-2026 Net Cash Flow is Rs 0 Cr which is growth of -99.6% YoY.

Camlin Fine Sciences Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
33.5%
11.1%
4421.982.118.546.82673.9-44.6-5.8-30.150.9
Cash from Investing Act. Ann.
-
-
-30.4-87.7-51.7-114.7-172.3-88-66-2.9-114.9-30.9-37.5
Cash from Financing Act. Ann.
-
-
-13.4101.2-34.178.4128.980.1-26.164.612061-13.1
-
-59.4%
0.235.4-3.7-17.83.418.1-18.217.1-0.700.3
*All financials are in INR Cr and price data in INR
Cash from Operating Act. Ann.
1Y CHG
100.9%
2Y CAGR
-26.8%
3Y CAGR
33.5%
5Y CAGR
11.1%
10Y CAGR
-1.4%
Cash from Operating Activity Annual growth is stable compared to historical averages.

Camlin Fine Sciences investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access